Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP379029.RA4RHcRhTS2OP8BWcU0ZlABr7j8XMMPAuEXo1EuVw2PKU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP379029.RA4RHcRhTS2OP8BWcU0ZlABr7j8XMMPAuEXo1EuVw2PKU130_assertion type Assertion NP379029.RA4RHcRhTS2OP8BWcU0ZlABr7j8XMMPAuEXo1EuVw2PKU130_head.
- NP379029.RA4RHcRhTS2OP8BWcU0ZlABr7j8XMMPAuEXo1EuVw2PKU130_assertion wasGeneratedBy ECO_0000203 NP379029.RA4RHcRhTS2OP8BWcU0ZlABr7j8XMMPAuEXo1EuVw2PKU130_provenance.
- NP379029.RA4RHcRhTS2OP8BWcU0ZlABr7j8XMMPAuEXo1EuVw2PKU130_assertion wasDerivedFrom befree-20150227 NP379029.RA4RHcRhTS2OP8BWcU0ZlABr7j8XMMPAuEXo1EuVw2PKU130_provenance.
- NP379029.RA4RHcRhTS2OP8BWcU0ZlABr7j8XMMPAuEXo1EuVw2PKU130_assertion SIO_000772 15753357 NP379029.RA4RHcRhTS2OP8BWcU0ZlABr7j8XMMPAuEXo1EuVw2PKU130_provenance.
- NP379029.RA4RHcRhTS2OP8BWcU0ZlABr7j8XMMPAuEXo1EuVw2PKU130_assertion evidence source_evidence_literature NP379029.RA4RHcRhTS2OP8BWcU0ZlABr7j8XMMPAuEXo1EuVw2PKU130_provenance.
- NP379029.RA4RHcRhTS2OP8BWcU0ZlABr7j8XMMPAuEXo1EuVw2PKU130_assertion description "[We sequenced the tyrosine kinase domain of HER2 in 671 primary non-small cell lung cancers (NSCLC), 80 NSCLC cell lines, and 55 SCLCs and other neuroendocrine lung tumors as well as 85 other epithelial cancers (breast, bladder, prostate, and colorectal cancers) and compared the mutational status with clinicopathologic features and the presence of EGFR or KRAS mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP379029.RA4RHcRhTS2OP8BWcU0ZlABr7j8XMMPAuEXo1EuVw2PKU130_provenance.